RADX नवीन इमेजिंग स्मॉल मॉलिक्यूल
सीमित कवरेज के साथ नया आख्यान — अभी भी बन रहा है।
शीर्ष मूवर्स
| टिकर | सेक्टर | परिवर्तन |
|---|---|---|
| Healthcare | +5.4% |
भावना समयरेखा
सेक्टर प्रदर्शन
स्टॉक प्रदर्शन
घटना समयरेखा
परिकल्पनाएँ
Radiopharm Theranostics will announce RAD101 adoption at minimum 5 major hospital networks or imaging centers within 12 months post-Siemens deal, indicating successful commercial penetration and clinical validation.
RPTX stock price will appreciate by minimum 20% within 90 days of Siemens supply deal announcement as market recognizes expanded commercial distribution and revenue visibility for RAD101 imaging product.
The Siemens Healthineers supply agreement for RAD101 will drive Radiopharm Theranostics' revenue growth by at least 15% YoY within 12 months following deal announcement, as evidenced by increased imaging procedure volume and market adoption.
शीर्ष मूवर्स
| टिकर | सेक्टर | परिवर्तन |
|---|---|---|
| Healthcare | +5.4% |